AbCellera Biologics (ABCL) Enterprise Value (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly Enterprise Value came in at -$102.1 million in Q1 2026, up 83.81% YoY from -$55.5 million in Q1 2025, and up 33.52% on a QoQ basis from -$153.5 million in Q4 2025.
AbCellera Biologics (ABCL) Enterprise Value (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of Enterprise Value data on file, last reported at -$102.1 million in Q1 2026.
- Quarterly Enterprise Value rose 83.81% year-over-year to -$102.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$102.1 million (up 83.81% YoY) and the FY2025 annual result came in at -$153.5 million, down 183.23% from the prior year.
- Enterprise Value improved to -$102.1 million in Q1 2026, from -$153.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$30.8 million in Q4 2023 to a low of -$1.0 billion in Q2 2022.
- A 5-year average of -$434.3 million and a median of -$397.0 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 96.62% — and 2025, when it tumbled 243.36%.
- Tracing ABCL's Enterprise Value over 5 years: stood at -$911.5 million in 2022, then soared by 96.62% to -$30.8 million in 2023, then sank by 75.97% to -$54.2 million in 2024, then plunged by 183.23% to -$153.5 million in 2025, then surged by 33.52% to -$102.1 million in 2026.
- The last three Enterprise Value figures came in at -$102.1 million (Q1 2026), -$153.5 million (Q4 2025), and -$520.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | -565.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -565.10 Mn |
| Mar 31, 2026 | -102.06 Mn |
| Dec 31, 2025 | -153.51 Mn |
| Sep 30, 2025 | -520.67 Mn |
| Jun 30, 2025 | -578.08 Mn |
| Mar 31, 2025 | -630.27 Mn |
| Dec 31, 2024 | -54.20 Mn |
| Sep 30, 2024 | -151.64 Mn |
| Jun 30, 2024 | -173.31 Mn |
| Mar 31, 2024 | -723.02 Mn |
| Dec 31, 2023 | -30.80 Mn |
| Sep 30, 2023 | -172.42 Mn |
| Jun 30, 2023 | -179.75 Mn |
| Mar 31, 2023 | -796.50 Mn |
| Dec 31, 2022 | -911.49 Mn |
| Sep 30, 2022 | -396.97 Mn |
| Jun 30, 2022 | -1.02 Bn |
| Mar 31, 2022 | -786.05 Mn |
| Dec 31, 2021 | -747.98 Mn |
| Sep 30, 2021 | -517.69 Mn |